Ken Griffin Zymeworks Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.43 $252,016 - $402,683	-54,197 Reduced 30.53%	123,327 $758,000
Q2 2022 Aug 15, 2022	SELL	$4.82 - $7.7 $512,751 - $819,126	-106,380 Reduced 37.47%	177,524 $941,000
Q1 2022 May 16, 2022	BUY	$6.0 - $16.98 $1.38 Million - $3.89 Million	229,379 Added 420.69%	283,904 $1.86 Million
Q4 2021 Feb 14, 2022	BUY	$15.19 - $29.33 $422,768 - $816,312	27,832 Added 104.27%	54,525 $893,000
Q3 2021 Nov 15, 2021	BUY	$27.35 - $37.28 $459,425 - $626,229	16,798 Added 169.76%	26,693 $775,000
Q2 2021 Aug 16, 2021	SELL	$26.5 - $38.23 $3.53 Million - $5.09 Million	-133,216 Reduced 93.09%	9,895 $343,000
Q1 2021 May 17, 2021	BUY	$29.83 - $56.81 $1.2 Million - $2.29 Million	40,288 Added 39.18%	143,111 $4.52 Million
Q4 2020 Feb 16, 2021	SELL	$39.12 - $54.99 $23.3 Million - $32.8 Million	-596,614 Reduced 85.3%	102,823 $4.86 Million
Q3 2020 Nov 16, 2020	SELL	$29.21 - $46.58 $6.4 Million - $10.2 Million	-219,013 Reduced 23.85%	699,437 $32.6 Million
Q2 2020 Aug 14, 2020	BUY	$33.67 - $40.0 $16.6 Million - $19.7 Million	492,964 Added 115.86%	918,450 $33.1 Million
Q1 2020 May 15, 2020	BUY	$24.28 - $49.8 $2.34 Million - $4.8 Million	96,348 Added 29.27%	425,486 $15.1 Million
Q4 2019 Feb 14, 2020	BUY	$24.84 - $45.46 $7.88 Million - $14.4 Million	317,384 Added 2700.22%	329,138 $15 Million
Q2 2019 Aug 14, 2019	SELL	$15.0 - $22.49 $19,230 - $28,832	-1,282 Reduced 9.83%	11,754 $259,000
Q1 2019 May 15, 2019	BUY	$14.02 - $16.74 $8,496 - $10,144	606 Added 4.88%	13,036 $0
Q4 2018 Feb 14, 2019	BUY	$10.95 - $15.44 $136,108 - $191,919	12,430 New	12,430 $182,000
Q1 2018 May 11, 2018	SELL	$7.93 - $13.41 $92,067 - $155,690	-11,610 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$6.87 - $9.19 $79,760 - $106,695	11,610	11,610 $88,000

Others Institutions Holding ZYME

# of Institutions

Shares Held

296K

Call Options Held

Put Options Held

Strategic Wealth Advisors Group, LLC Sacramento, CA

296K
Shares

$4.41 Million
0.08% of portfolio

View Full List

About Zymeworks Inc.

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $917M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

More about ZYME

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account